You are here

Article Text

Article menu

Download PDFPDF

Electronic pages
Correspondence
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
Free
  1. Rudra Prosad Goswami,
  2. Kaushik Basu,
  3. Shyamashis Das,
  4. Sumantro Mondal,
  5. Parasar Ghosh,
  6. Alakendu Ghosh
  1. Department of Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India
  1. Correspondence to Dr Rudra Prosad Goswami, Abhyudoy Housing, Flat 18/14, ECTP, Ph IV, Type B, EM Bypass, Kolkata 700107, West Bengal, India; rudra.goswami{at}gmail.com

https://doi.org/10.1136/annrheumdis-2015-209094

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest a recent paper by Stoffer et al1 on treat to target (T2T) evidence for rheumatoid arthritis (RA) published in the current issue of the journal.

    The systematic literature review provided newer evidence by building on the existing 2010 T2T recommendations for RA.2 Based on this paper, the 2014 recommendation update was also published in the same issue. We congratulate the authors for performing thorough evidence summary. However, we would like to share a few concerns pertaining to the present paper.

    The authors comment in their results section regarding the cost-effectiveness of the T2T strategy depending on a paper by Vermeer et al.3

    Methotrexate monotherapy, when applied to patients with RA naïve to combination synthetic disease modifying anti rheumatic therapy (csDMARD), affords a disease activity score (DAS)28-based remission in 20%–25% patients …

    View Full Text

    Linked Articles